CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole (Q46101359)
Jump to navigation
Jump to search
scientific article published on 4 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole |
scientific article published on 4 March 2009 |
Statements
1 reference
CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole (English)
1 reference
Takahisa Furuta
1 reference
Mitsushige Sugimoto
1 reference
Chise Kodaira
1 reference
Masafumi Nishino
1 reference
Mihoko Yamade
1 reference
Mutsuhiro Ikuma
1 reference
Naohito Shirai
1 reference
Hiroshi Watanabe
1 reference
Kazuo Umemura
1 reference
Michio Kimura
1 reference
Akira Hishida
1 reference
4 March 2009
1 reference
65
1 reference
7
1 reference
693-698
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference